2019
DOI: 10.1002/oa.2736
|View full text |Cite
|
Sign up to set email alerts
|

Leukemia in Ancient Egypt: Earliest case and state‐of‐the‐art techniques for diagnosing generalized osteolytic lesions

Abstract: Malignant bone tumors are uncommon among archaeological skeletal remains, and the general skeletal involvement is even less frequent. Multiple myelomas along with metastases are the most common conditions in paleopathology, whereas malignant myeloproliferative diseases have only been described in a handful of cases. We present a probable case of acute lymphocytic leukemia in a skeleton of an individual from Ancient Egypt, dated to the end of the First Intermediate Period and the beginning of the Middle Kingdom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 26 publications
(51 reference statements)
1
3
0
Order By: Relevance
“…Moving on to leukaemia, its distinctive marks could be identified in the presence of fronts of resorption, erosion, and pitting of the bones, with marginal amount of new bone formation. These, generally spread both in cranial and postcranial elements, are the distinctive marks of leukaemia that have not been observed in our case (Isidro, Seiler, & Seco, ; Ortner, ; Rothschild et al, ; see also clinical data: Juliusson & Hough, ).…”
Section: Discussionsupporting
confidence: 69%
“…Moving on to leukaemia, its distinctive marks could be identified in the presence of fronts of resorption, erosion, and pitting of the bones, with marginal amount of new bone formation. These, generally spread both in cranial and postcranial elements, are the distinctive marks of leukaemia that have not been observed in our case (Isidro, Seiler, & Seco, ; Ortner, ; Rothschild et al, ; see also clinical data: Juliusson & Hough, ).…”
Section: Discussionsupporting
confidence: 69%
“…Less commonly, the entire skeleton was imaged to characterize a suspected disease process or to provide as complete an assessment as possible. Such complete evaluations of individual skeletons have shown, for example, diffuse skeletal lesions consistent with syphilis (Mansilla & Pijoan, 1995); lytic lesions (Lewis, 1998); erosions suggestive of juvenile arthritis (Rothschild et al, 1997); evidence for osteogenesis imperfecta (Cope & Dupras, 2011); skeletal stigmata of child abuse (Blondiaux et al, 2002; Wheeler et al, 2013); diffuse cortical porosity and subperiosteal bone deposition felt to represent renal osteodystrophy (Mays & Turner‐Walker, 2008); lytic lesions suggestive of acute lymphocytic leukemia (Isidro et al, 2019); and metabolic deficiency (Wheeler et al, 2013). Such studies reveal the importance of imaging the entire skeleton, as minor lesions may not be visible macroscopically on bone surfaces (Western & Bekvalac, 2015).…”
Section: Literature Review: Resultsmentioning
confidence: 99%
“…Interestingly, there are at least five published paleopathological reports with mention to metastases in the hands and/or feet, including one young male with lymphocytic leukemia (Isidro et al, 2019) and in diagnosis of MBD of four adults (Fornaciari et al, 2009;Luna et al, 2015;Minozzi et al, 2018;Strouhal, 1993). Considering the T A B L E 2 Summary of the lesions' distribution and main features (individual from burial number 3 from the Chapel of the Convent of the Holy Spirit, Portugal).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, there are at least five published paleopathological reports with mention to metastases in the hands and/or feet, including one young male with lymphocytic leukemia (Isidro et al, 2019) and in diagnosis of MBD of four adults (Fornaciari et al, 2009; Luna et al, 2015; Minozzi et al, 2018; Strouhal, 1993). Considering the alleged rarity of cancers in past populations, it is surprising that acrometastases are apparently more frequent (~2%, 6/~270 to 300 published cancers; Hunt et al, 2018; Marques et al, 2021) in the past when compared with current clinical landscape.…”
Section: Discussionmentioning
confidence: 99%